بررسي شيوع ميكروآلبومينوري در بيماران مبتلا به ديابت نوع 2 كنترل نشده مراجعه كننده به مركز تحقيقات ديابت يزد در سالهاي 82-1381

Prevalence of microalbuminuria in type 2 Diabetic patients reffered to yazd diabetes research centre

Background and purpose: Diabetes is one the most common metabolic disease. 4.5-6% of Iranian and 14.2% of Yazd people suffer from diabetes. Microalbuminuria occure before the developement of nephropathy, hence if detected at an early stage, effective therapy can be implemented by normalizaing of glycemia, strict blood pressure control and administration of ACE inhibitors. The aim of this study was to determine the prevalence of microalbuminuria and its correlation with sex, fasting blood glacose, 2 hours post prandial blood sugar, HbAIC and duration of diabetes among type 2 diabetic patients attending Yazd diabetes centre. Materials and methods : A cross sectional study was under taken from November 2002 to july 2003 to investigate the prevalence of microalbuminuria. 288type 2 diabetic patients (141 male and 147 female) visited at Yazd diabetes center were examined through connective sampling. Results: Overall prevalence of microalbuminuria was 14.2%, males 14.9% and in males and females respective 13.6% Chi- square analysis revealed that duration of diabetes is associated with microalbuminuria (Pvalue).001). No statiscally significant correlation was found between microalbuminuria and FBS, 2HPP(BS), sex and HbAIC. Conclusion: The Overall prevalence of microalbuminuria in this study was similar to that reported in India (15.7%) and Saudi arabia(16.8%). Considering the high rate of diabetic nephropathy, microalbuminuria screening tests are the best was in diabetic nephropathy diagnosis, treatment and prevention of end stage renal disease.